Benitec Biopharma Limited Consolidated Net Income/Loss

Consolidated Net Income/Loss of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending June 30, 2022 was $-5.07 Million (a 54.72% increase compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss increased by 0.44%
  • Annual Consolidated Net Income/Loss for 2022 was $-18.2 Million (a 31.16% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2021 was $-13.9 Million (a -0.0% decrease from previous year)
  • Annual Consolidated Net Income/Loss for 2021 was $-13.9 Million (a 67.78% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending June 30, 2022 was $-18.2 Million (a 6.21% increase compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss increased by 12.33% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$-18.2 Million $-17.1 Million $-17.8 Million $-16.2 Million
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of Benitec Biopharma Limited

Most recent Consolidated Net Income/Lossof BNTC including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of Benitec Biopharma Limited

Benitec Biopharma Limited Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-5.07 $-3.28 $-18.21
2021 $-4.82 $-5.05 $-4.0 $-3.91 $-13.88
2020 $-3.25 $-2.72 $-2.94 $-2.1 $-8.27
2019 $-2.09 $-1.15 $2.61
2018 $-9.02
2017 $-2.27 $-4.29
2016 $0.56 $-18.05
2015 $-9.64
2014 $-6.46
2013 $-3.58

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology